DIMENSIONAL FUND ADVISORS LP

Position in ROIV — Roivant Sciences Ltd.

CIK 354204 AUSTIN, TX

Position in ROIV

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$185,104,455

-$21,977,031 QoQ

Shares Held

5,230,417

-30.0% QoQ

Ownership

0.724%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#23

of 489 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 83% Shared 14% None 3%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,102,677,105 across 230 Biotechnology names. ROIV ranks #7 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd. This page	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$185,104,455	5,230,417	-30.0%	Shares	Sole	2026-08-11
2026-03-31	$207,081,486	7,475,866	-19.2%	Shares	Sole	2026-05-07
2025-12-31	$200,670,054	9,247,468	-0.7%	Shares	Sole	2026-02-12
2025-09-30	$140,840,779	9,308,710	+18.0%	Shares	Sole	2025-11-12
2025-06-30	$88,871,116	7,885,636	+204.7%	Shares	Sole	2025-08-12
2025-03-31	$26,111,082	2,587,818	+1870.7%	Shares	Sole	2025-05-13
2024-12-31	$1,553,444	131,314	-35.3%	Shares	Sole	2025-02-13
2024-09-30	$2,341,937	202,941	-19.7%	Shares	Sole	2024-11-07
2024-06-30	$2,671,260	252,721	—	Shares	Sole	2024-08-09
No filing history on record for this holder in this stock.